Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjun Qiu

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Iscience|July 2, 2026
Corrigendum to Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer [iScience Volume 29, Issue 3, March 2026, Article e114872]Jiani Wu, Yuanyuan Wang, Zhenhua Huang, et al.
Medcomm|August 27, 2025
Artificial Intelligence-Based Multimodal Prediction of Postoperative Adjuvant Immunotherapy Benefit in Urothelial Carcinoma: Results From the Phase III, Multicenter, Randomized, IMvigor010 TrialXiatong Huang, Wenjun Qiu, Yuyun Kong, et al.
Journal for Immunotherapy of Cancer|August 11, 2021
Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancerDongqiang Zeng, Jiani Wu, Huiyan Luo, et al.
Cell Metabolism|June 19, 2024
Nicotinamide metabolism face-off between macrophages and fibroblasts manipulates the microenvironment in gastric cancerYu Jiang, Yawen Wang, Guofeng Chen, et al.
Cancer Science|September 27, 2024
Dynamic single-cell sequencing unveils the tumor microenvironment evolution of gastric cancer abdominal wall metastases during radiotherapyQianqian Mao, Zhenzhen Wu, Yonghong Lai, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 28, 2025
Immunotyping the Tumor Microenvironment Reveals Molecular Heterogeneity for Personalized Immunotherapy in CancerDongqiang Zeng, Yunfang Yu, Wenjun Qiu, et al.
Med (New York, N.Y.)|August 1, 2024
Tumor microenvironment RNA test to predict immunotherapy outcomes in advanced gastric cancer: The TIMES001 trialMin Shi, Dongqiang Zeng, Huiyan Luo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 29, 2025
Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical TrialsZhaojun Wang, Yiran Fang, Xiatong Huang, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Iscience|July 2, 2026
Corrigendum to Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer [iScience Volume 29, Issue 3, March 2026, Article e114872]Jiani Wu, Yuanyuan Wang, Zhenhua Huang, et al.
Medcomm|August 27, 2025
Artificial Intelligence-Based Multimodal Prediction of Postoperative Adjuvant Immunotherapy Benefit in Urothelial Carcinoma: Results From the Phase III, Multicenter, Randomized, IMvigor010 TrialXiatong Huang, Wenjun Qiu, Yuyun Kong, et al.
Journal for Immunotherapy of Cancer|August 11, 2021
Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancerDongqiang Zeng, Jiani Wu, Huiyan Luo, et al.
Cell Metabolism|June 19, 2024
Nicotinamide metabolism face-off between macrophages and fibroblasts manipulates the microenvironment in gastric cancerYu Jiang, Yawen Wang, Guofeng Chen, et al.
Cancer Science|September 27, 2024
Dynamic single-cell sequencing unveils the tumor microenvironment evolution of gastric cancer abdominal wall metastases during radiotherapyQianqian Mao, Zhenzhen Wu, Yonghong Lai, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 28, 2025
Immunotyping the Tumor Microenvironment Reveals Molecular Heterogeneity for Personalized Immunotherapy in CancerDongqiang Zeng, Yunfang Yu, Wenjun Qiu, et al.
Med (New York, N.Y.)|August 1, 2024
Tumor microenvironment RNA test to predict immunotherapy outcomes in advanced gastric cancer: The TIMES001 trialMin Shi, Dongqiang Zeng, Huiyan Luo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 29, 2025
Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical TrialsZhaojun Wang, Yiran Fang, Xiatong Huang, et al.
Pageof 4